Bob Chapman

The battle over Herbalife (NYSE: HLF) has raged for months now, with hedge fund titans battling it out over the future of this stock. Notably, Carl Icahn of Icahn Enterprises (NYSE: IEP) has bought over 16 percent of the stock while Bill Ackman of Pershing Square Capital has taken a large short...

Shares of Herbalife (NYSE: HLF) surged almost 10 percent Thursday, catapulting the California-based maker of dietary supplements and weight management products to a July gain of 43 percent. Put simply, Herbalife is becoming the toast of the hedge fund universe as rivals look to burn Pershing...

As promised, Bill Ackman's Pershing Square released a 40 page document on Thursday laying out dozens of questions aimed at Herbalife's (NYSE: HLF) management. Readers can view the questions here. Some of the questions are particularly technical in nature and relate to old legal battles the...

According to The New York Post, Dan Loeb is short Nu Skin (NYSE: NUS). Shares of the multi-level marketer dropped nearly 2 percent early on Tuesday. This stands in sharp contrast to Loeb's ownership of Herbalife (NYSE: HLF) shares. Both stocks have traded largely in tandem over the last few months...

The Herbalife (NYSE: HLF) battle is shaping up to be the bloodiest hedge fund battle ever, having pulled in Bill Ackman, Dan Loeb, and Bob Chapman. Today, The New York Post is reporting that legendary activist investor Carl Icahn has entered the fray by taking a long position in the stock. This...

Shares of Herbalife (NYSE: HLF) were halted on circuit breaker Wednesday after Dan Loeb's Third Point filed a 13D revealing an 8.2 percent stake. Herbalife has been an extremely volatile stock over the last few months. In December, Pershing Square's Bill Ackman revealed that he sold short about...